Nasdaq IPOs

Glenfarne Merger, a blank check company formed by Glenfarne Group targeting energy transition and electrification, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The

CAVU Technology Acquisition, a blank check company formed by the co-founders of CAVU Capital targeting tech, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The Tampa, FL-based company plans to raise $100 million by offering 10 million u

Good Works II Acquisition, a blank check company targeting high-growth businesses, filed on Thursday with the SEC to raise up to $200 million in an initial public offering. The Houston, TX-based company plans to raise $200 million by offering 20 million units at $10. Each unit c

Healthcare Merger II, a blank check company led by Steven Shulman and William Sanger targeting the healthcare industry, filed on Thursday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offerin

Quiet Plus I Acquisition, a blank check company formed by Quiet Capital targeting the tech sector, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Seattle, WA-based company plans to raise $250 million by offering 25 million units at

agilon health, which provides a senior-focused value-based care platform for primary care physicians, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. Capitalizing on emerging value-based care opportunities, agilon's model provides the ne

The Renaissance International IPO Index (Ticker: IPOXUS), the underlying index for the Renaissance International IPO ETF (Ticker: IPOS), will implement the following constituent changes effective Monday, March 22, 2021: Additions: AUTO1 Group Akeso Blue Moon Group CSN Miner

Instil Bio, an early stage biotech developing immune cell therapies for cancer, raised the proposed deal size for its upcoming IPO on Thursday. The Dallas, TX-based company now plans to raise $312 million by offering 16 million shares at a price range of $19 to $20. The company

CHW Acquisition, a blank check company targeting consumer products and retail, filed on Thursday with the SEC to raise up to $100 million in an initial public offering. The Purchase, NY-based company plans to raise $100 million by offering 10 million units at $10. Each unit will

Red Cell DRM Acquisition, a blank check company targeting businesses driving the electrical power grid transition, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Beverly Hills, CA-based company plans to raise $250 million by offerin

Olink Holding, which provides a platform of proteome analysis products for biomedical research, announced terms for its IPO on Thursday. The Uppsala, Sweden-based company plans to raise $300 million by offering 17.6 million ADSs (25% insider) at a price range of $16 to $18.&nbsp

Keter1 Acquisition, a blank check company targeting technology companies in Israel, filed on Thursday with the SEC to raise up to $250 million in an initial public offering. The Claymont, DE-based company plans to raise $250 million by offering 25 million units at $10. Each unit

Stellaris Growth Acquisition, a blank check company focusing on the data centers and internet technology sectors, filed on Thursday with the SEC to raise up to $128 million in an initial public offering. The Jakarta, Indonesia-based company plans to raise $128 million by offerin

Tuya, which provides a consumer interface platform for smart device makers in China, raised $915 million by offering 43.6 million ADSs at $21, above the range of $17 to $20. Insiders Tencent and Hillhouse Capital, and new investors CPPIB, Dragoneer Investment Group, GIC, and

DILA Capital Acquisition, a blank check company formed by DILA Capital targeting tech-enabled sectors in Latin America, filed on Thursday with the SEC to raise up to $50 million in an initial public offering. The Miami, FL-based company plans to raise $50 million by offering 5 m

LAVA Therapeutics, a Dutch Phase 1/2a biotech developing gamma-delta T cell therapies for cancer, announced terms for its IPO on Thursday. The Utrecht, Netherlands-based company plans to raise $101 million by offering 6.7 million shares at a price range of $14 to $16. At the mid

Alignment Healthcare, which provides Medicare Advantage plans to seniors, announced terms for its IPO on Thursday. The Orange, CA-based company plans to raise $490 million by offering 27.2 million shares (20% insider) at a price range of $17 to $19. At the midpoint of the propos

The Duckhorn Portfolio, which produces and distributes luxury wine in North America, raised $300 million by offering 20 million shares (33% secondary) at $15, within the range of $14 to $16. Based in Napa Valley, Duckhorn produces and sells a portfolio of luxury wines in all 50

Gain Therapeutics, a preclinical biotech developing small molecule therapies for lysosomal storage disorders, raised $40 million by offering 3.6 million shares at $11, within the range of $10 to $12. At pricing, the company commands a fully diluted market value of $129 million.

Research Alliance II, the second blank check company formed by RA Capital targeting the biotech industry, raised $130 million by offering 13 million shares at $10. The company did not offer units with warrants attached. It may raise an additional $30 million at the closing o